January 2, 2009 - Jennifer Mieres, M.D., associate professor of medicine and director of nuclear cardiology (ASNC) at New York University, assumes the presidency of the American Society of Nuclear Cardiology today with a call to physicians, scientists, and technologists to emphasize patient outcomes and restore patient trust in the world of cardiovascular imaging.

December 31, 2008 – According to results from a Phase 2 clinical study (BP-23), Zemiva, when combined with the standard of care for the diagnostic evaluation of the chest pain patient, improved sensitivity for the detection of cardiac ischemia by more than 50 percent (p

December 31, 2008 - The FDA today approved Vasovist Injection (gadofosveset trisodium), manufactured by EPIX Pharmaceuticals, is reportedly the first contrast imaging agent for use in patients undergoing magnetic resonance angiography (MRA).

December 30, 2008 - Sapheneia, a global, ISO-certified imaging services company specializing in diagnostic and analytical image processing solutions, signed an agreement with Karolinska University Hospital in Stockholm, Sweden, allowing Karolinska University Hospital to use and evaluate the Sapheneia Clarity CT Solution to lower radiation dose exposure to patients during diagnostic image studies.

December 31, 2008 - ZOLL Medical Corp. said today Provena St. Joseph Hospital in Elgin, IL implemented the company’s AutoPulse Non-Invasive Cardiac Support Pump in the hospital’s intensive care and cardiac care units.

December 30, 2008 - Volcano Corp. will acquire Axsun Technologies Inc., a developer and manufacturer of lasers and optical engines used in medical Optical Coherence Tomography (OCT) imaging systems and advanced photonic components, as part of Volcano’s strategy to establish its position in invasive imaging.

December 30, 2008 - Merit Medical Systems Inc., a manufacturer of disposable devices used in cardiology and radiology procedures, today announced four developments regarding products and approvals.

December 29, 2008 – When Zemiva, an imaging agent by Molecular Insight Pharmaceuticals Inc., is combined with the standard of care for the diagnostic evaluation of the chest pain patient, improved the detection of cardiac ischemia by more than 50 percent greater than the standard of care when compared to the standard of care alone.

December 29, 2008 - Calgary Scientific Inc. plans to release its ResolutionMD Cardiac advanced visualization suite of clinical modules for viewing and analyzing cardiac CT and MR images in early 2009.

December 29, 2008 - Edwards Lifesciences Corp. said last week it will voluntarily disclose financial relationships with U.S. physicians starting in 2009.

Edwards plans to begin posting on a page on its Web site its financial relationships with physicians who receive $5,000 or more a year in consulting fees, royalties or honoraria from Edwards. The company will begin targeted tracking of this data on Jan. 1 and will publish it annually beginning in the second half of 2009.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now